The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Genetic and biological hallmarks of colorectal cancer
Open accessAbstract
Colorectal cancer has served as a genetic and biological paradigm for the evolution of solid tumors, and these insights have illuminated early detection, risk stratification, prevention, and treatment principles. Employing the hallmarks of cancer framework, we provide a conceptual framework to understand how genetic alterations in colorectal cancer drive cancer cell biology properties and shape the heterotypic interactions across cells in the tumor microenvironment. This review details research advances pertaining to the genetics and biology of colorectal cancer, emerging concepts gleaned from immune and single-cell profiling, and critical advances and remaining knowledge gaps influencing the development of effective therapies for this cancer that remains a major public health burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 418
Dclk1 distinguishes between tumor and normal stem cells in the intestine
Nakanishi, Y., Seno, H., Fukuoka, A., Ueo, T., Yamaga, Y., Maruno, T., Nakanishi, N., Kanda, K., Komekado, H., Kawada, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2481 · Cited by 406
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
Rubin, D. C., Shaker, A., & Levin, M. S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00107 · Cited by 404
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Kadosh, E., Snir-Alkalay, I., Venkatachalam, A., May, S., Lasry, A., Elyada, E., Zinger, A., Shaham, M., Vaalani, G., Mernberger, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2541-0 · Cited by 378 · cited 1×
“Strikingly, the gut microbiome can also influence the function of p53 by switching mutant p53 from tumor-suppressive to oncogenic through a singlemicrobiota-derivedmetabolite, gal- lic acid (Kadosh et al. 2020), further emphasizing the need to understand the role of the microbiome in tumor biology.”
BackgroundFrequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
Vaughn, C. P., ZoBell, S. D., Furtado, L. V., Baker, C. L., & Samowitz, W. S. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20854 · Cited by 377
Mucida, D., Husain, M. M., Muroi, S., van Wijk, F., Shinnakasu, R., Naoe, Y., Reis, B. S., Huang, Y., Lambolez, F., Docherty, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2523 · Cited by 376
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0013 · Cited by 375
KRAS Alleles: The Devil Is in the Detail
Haigis, K. M. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.08.006 · Cited by 373
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373
Dasari, A., Morris, V. K., Allegra, C. J., Atreya, C., Benson, A. B., Boland, P., Chung, K., Copur, M. S., Corcoran, R. B., Deming, D. A., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0392-0 · Cited by 372
Accioly, M. T., Pacheco, P., Maya-Monteiro, C. M., Carrossini, N., Robbs, B. K., Oliveira, S. S., Kaufmann, C., Morgado-Diaz, J. A., Bozza, P. T., & Viola, J. P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1999 · Cited by 365
Gaudier, E., Jarry, A., Blottière, H. M., de Coppet, P., Buisine, M. P., Aubert, J. P., Laboisse, C., Cherbut, C., & Hoebler, C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00219.2004 · Cited by 365
Schell, J. C., Olson, K. A., Jiang, L., Hawkins, A. J., Van Vranken, J. G., Xie, J., Egnatchik, R. A., Earl, E. G., DeBerardinis, R. J., & Rutter, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.026 · Cited by 363 · cited 1×
“Accordingly, re-expressing MPC increases mitochondrial pyruvate oxidation and impairs anchorage-independent growth of CRC cells (Schell et al. 2014).”
BackgroundIn vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
Roper, J., Tammela, T., Cetinbas, N. M., Akkad, A., Roghanian, A., Rickelt, S., Almeqdadi, M., Wu, K., Oberli, M. A., Sánchez-Rivera, F. J., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3836 · Cited by 348
Chromosomal instability in ulcerative colitis is related to telomere shortening
O'Sullivan, J. N., Bronner, M. P., Brentnall, T. A., Finley, J. C., Shen, W.-T., Emerson, S., Emond, M. J., Gollahon, K. A., Moskovitz, A. H., Crispin, D. A., et al. (2002) · Nature Genetics · doi:10.1038/ng989 · Cited by 346 · cited 2×
“Accelerated telomere attrition has been documented in the colon of UC patients, supporting the hypothesis that resultant CIN contributes to increased CRC occurrence (O’Sullivan et al. 2002; Risques et al. 2008).”
BackgroundResultIs cancer a disease of self-seeding?
Norton, L., & Massagué, J. (2006) · Nature Medicine · doi:10.1038/nm0806-875 · Cited by 346
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Irrazábal, T., Belcheva, A., Girardin, S. E., Martin, A., & Philpott, D. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.039 · Cited by 344
Allen, J. E., Krigsfeld, G., Mayes, P. A., Patel, L., Dicker, D. T., Patel, A. S., Dolloff, N. G., Messaris, E., Scata, K. A., Wang, W., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004828 · Cited by 342
Shen, Y., Wang, X., Lu, J., Salfenmoser, M., Wirsik, N. M., Schleussner, N., Imle, A., Freire Valls, A., Radhakrishnan, P., Liang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.005 · Cited by 339
Metabolic Reprogramming of Stem Cell Epigenetics
Ryall, J. G., Cliff, T., Dalton, S., & Sartorelli, V. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.11.012 · Cited by 328
Metabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 328
Self-citationTumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Erreni, M., Mantovani, A., & Allavena, P. (2011) · Cancer Microenvironment · doi:10.1007/s12307-010-0052-5 · Cited by 325
Bu, P., Chen, K.-Y., Xiang, K., Johnson, C., Crown, S. B., Rakhilin, N., Ai, Y., Wang, L., Xi, R., Astapova, I., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.003 · Cited by 324
Self-citationPlasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer
Fumagalli, A., Oost, K. C., Kester, L., Morgner, J., Bornes, L., Bruens, L., Spaargaren, L., Azkanaz, M., Schelfhorst, T., Beerling, E., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.008 · Cited by 319
Somatic Mutations of EGFR in Colorectal Cancers and Glioblastomas
Barber, T. D., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412303512724 · Cited by 315
Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation
Hinoi, T., Akyol, A., Theisen, B. K., Ferguson, D. O., Greenson, J. K., Williams, B. O., Cho, K. R., & Fearon, E. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2735 · Cited by 314
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
Kavuri, S. M., Jain, N., Galimi, F., Cottino, F., Leto, S. M., Migliardi, G., Searleman, A. C., Shen, W., Monsey, J., Trusolino, L., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1211 · Cited by 302 · cited 2×
“2; Kavuri et al. 2015).”
BackgroundThe molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Medico, E., Russo, M., Picco, G., Cancelliere, C., Valtorta, E., Corti, G., Buscarino, M., Isella, C., Lamba, S., Martinoglio, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8002 · Cited by 302
BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
Sanz-Garcia, E., Argiles, G., Elez, E., & Tabernero, J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx401 · Cited by 302
Janssen, K., Alberici, P., Fsihi, H., Gaspar, C., Breukel, C., Franken, P., Rosty, C., Abal, M., El Marjou, F., Smits, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.011 · Cited by 298
Schwitalla, S., Ziegler, P. K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y., Lechel, A., Rudolph, K. L., Langer, R., Slotta-Huspenina, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.014 · Cited by 296
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
Hao, Y., Samuels, Y., Li, Q., Krokowski, D., Guan, B.-J., Wang, C., Jin, Z., Dong, B., Cao, B., Feng, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11971 · Cited by 290
Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
Jaiswal, B. S., Janakiraman, V., Kljavin, N. M., Chaudhuri, S., Stern, H. M., Wang, W., Kan, Z., Dbouk, H. A., Peters, B. A., Waring, P., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.016 · Cited by 289
Van den Eynde, M., Mlecnik, B., Bindea, G., Fredriksen, T., Church, S. E., Lafontaine, L., Haicheur, N., Marliot, F., Angelova, M., Vasaturo, A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.003 · Cited by 281
Innate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease
Sonnenberg, G. F., & Artis, D. (2012) · Immunity · doi:10.1016/j.immuni.2012.10.003 · Cited by 277
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Malekzadeh, P., Pasetto, A., Robbins, P. F., Parkhurst, M. R., Paria, B. C., Jia, L., Gartner, J. J., Hill, V., Yu, Z., Restifo, N. P., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123791 · Cited by 275
COX-2 inhibition and colorectal cancer
Koehne, C.-H., & Dubois, R. N. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.041 · Cited by 273
Ji, Q., Zhou, L., Sui, H., Yang, L., Wu, X., Song, Q., Jia, R., Li, R., Sun, J., Wang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14869-x · Cited by 267
Fu, Y., Liu, S., Yin, S., Niu, W., Xiong, W., Tan, M., Li, G., & Zhou, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18175 · Cited by 263
p53/HMGB1 Complexes Regulate Autophagy and Apoptosis
Livesey, K. M., Kang, R., Vernon, P., Buchser, W., Loughran, P., Watkins, S. C., Zhang, L., Manfredi, J. J., Zeh, H. J., Li, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2291 · Cited by 262
Rahbari, N. N., Kedrin, D., Incio, J., Liu, H., Ho, W. W., Nia, H. T., Edrich, C. M., Jung, K., Daubriac, J., Chen, I., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5219 · Cited by 258
Woolston, A., Khan, K., Spain, G., Barber, L. J., Griffiths, B., Gonzalez-Exposito, R., Hornsteiner, L., Punta, M., Patil, Y., Newey, A., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.013 · Cited by 254
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
Voloshanenko, O., Erdmann, G., Dubash, T. D., Augustin, I., Metzig, M., Moffa, G., Hundsrucker, C., Kerr, G., Sandmann, T., Anchang, B., et al. (2013) · Nature Communications · doi:10.1038/ncomms3610 · Cited by 251
Suh, Y., Afaq, F., Johnson, J. J., & Mukhtar, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn269 · Cited by 251
Stem cell dynamics in homeostasis and cancer of the intestine
Vermeulen, L., & Snippert, H. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3744 · Cited by 247
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Takada, K., Zhu, D., Bird, G. H., Sukhdeo, K., Zhao, J.-J., Mani, M., Lemieux, M., Carrasco, D. E., Ryan, J., Horst, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003808 · Cited by 245
Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids
Bolhaqueiro, A. C. F., Ponsioen, B., Bakker, B., Klaasen, S. J., Kucukkose, E., van Jaarsveld, R. H., Vivié, J., Verlaan-Klink, I., Hami, N., Spierings, D. C. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0399-6 · Cited by 243
MYC and the Control of Apoptosis
McMahon, S. B. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014407 · Cited by 240
Abdulamir, A. S., Hafidh, R. R., & Bakar, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-249 · Cited by 240
A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., Burstain, I., Morgenstern, Y., Brachya, G., Billauer, H., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.005 · Cited by 239
Protein turnover by the proteasome in aging and disease
Shringarpure, R., & Davies, K. J. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00824-9 · Cited by 237
Dienstmann, R., Mason, M. J., Sinicrope, F. A., Phipps, A. I., Tejpar, S., Nesbakken, A., Danielsen, S. A., Sveen, A., Buchanan, D. D., Clendenning, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx052 · Cited by 237
Stem cells and their implications for colorectal cancer
Zeki, S. S., Graham, T. A., & Wright, N. A. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.211 · Cited by 235
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
Wang, H., Franco, F., & Ho, P.-C. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.06.005 · Cited by 234
Doubeni, C. A., Major, J. M., Laiyemo, A. O., Schootman, M., Zauber, A. G., Hollenbeck, A. R., Sinha, R., & Allison, J. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs346 · Cited by 231
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
Masugi, Y., Nishihara, R., Yang, J., Mima, K., da Silva, A., Shi, Y., Inamura, K., Cao, Y., Song, M., Nowak, J. A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311421 · Cited by 231
Recurrent KRAS codon 146 mutations in human colorectal cancer
Edkins, S., & O’Meara, S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.8.3251 · Cited by 229
Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer
Leung, M. L., Davis, A., Gao, R., Casasent, A., Wang, Y., Sei, E., Vilar, E., Maru, D., Kopetz, S., & Navin, N. E. (2017) · Genome Research · doi:10.1101/gr.209973.116 · Cited by 220
DIETARY INTAKE AND COLON CANCER: SEX- AND ANATOMIC SITE-SPECIFIC ASSOCIATIONS
WEST, D. W., SLATTERY, M. L., ROBISON, L. M., SCHUMAN, K. L., FORD, M. H., MAHONEY, A. W., LYON, J. L., & SORENSEN, A. W. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115421 · Cited by 214
Seubert, B., Grünwald, B., Kobuch, J., Cui, H., Schelter, F., Schaten, S., Siveke, J. T., Lim, N. H., Nagase, H., Simonavicius, N., et al. (2015) · Hepatology · doi:10.1002/hep.27378 · Cited by 213
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
Ertych, N., Stolz, A., Stenzinger, A., Weichert, W., Kaulfuß, S., Burfeind, P., Aigner, A., Wordeman, L., & Bastians, H. (2014) · Nature Cell Biology · doi:10.1038/ncb2994 · Cited by 213
He, B., Reguart, N., You, L., Mazieres, J., Xu, Z., Lee, A. Y., Mikami, I., McCormick, F., & Jablons, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208511 · Cited by 212
Martin, S. A., McCabe, N., Mullarkey, M., Cummins, R., Burgess, D. J., Nakabeppu, Y., Oka, S., Kay, E., Lord, C. J., & Ashworth, A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.046 · Cited by 204
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
Boutin, A. T., Liao, W.-T., Wang, M., Hwang, S. S., Karpinets, T. V., Cheung, H., Chu, G. C., Jiang, S., Hu, J., Chang, K., et al. (2017) · Genes & Development · doi:10.1101/gad.293449.116 · Cited by 195
Self-citationThaker, A. I., Rao, M. S., Bishnupuri, K. S., Kerr, T. A., Foster, L., Marinshaw, J. M., Newberry, R. D., Stenson, W. F., & Ciorba, M. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.002 · Cited by 194
Stern, J. L., Theodorescu, D., Vogelstein, B., Papadopoulos, N., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.269498.115 · Cited by 189
Yuzhalin, A. E., Gordon-Weeks, A. N., Tognoli, M. L., Jones, K., Markelc, B., Konietzny, R., Fischer, R., Muth, A., O’Neill, E., Thompson, P. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07306-7 · Cited by 188
Regionalized Development and Maintenance of the Intestinal Adaptive Immune Landscape
Agace, W. W., & McCoy, K. D. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.004 · Cited by 187
Song, X., Gao, H., Lin, Y., Yao, Y., Zhu, S., Wang, J., Liu, Y., Yao, X., Meng, G., Shen, N., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.018 · Cited by 185
Narasimhan, V., Wright, J. A., Churchill, M., Wang, T., Rosati, R., Lannagan, T. R. M., Vrbanac, L., Richardson, A. B., Kobayashi, H., Price, T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0073 · Cited by 185
Voorneveld, P. W., Kodach, L. L., Jacobs, R. J., Liv, N., Zonnevylle, A. C., Hoogenboom, J. P., Biemond, I., Verspaget, H. W., Hommes, D. W., de Rooij, K., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.052 · Cited by 183
β -catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis
van Veelen, W., Le, N. H., Helvensteijn, W., Blonden, L., Theeuwes, M., Bakker, E. R. M., Franken, P. F., van Gurp, L., Meijlink, F., van der Valk, M. A., et al. (2011) · Gut · doi:10.1136/gut.2010.233460 · Cited by 183
mTOR pathway in colorectal cancer: an update
Francipane, M. G., & Lagasse, E. (2014) · Oncotarget · doi:10.18632/oncotarget.1548 · Cited by 182
Claspin Operates Downstream of TopBP1 To Direct ATR Signaling towards Chk1 Activation
Liu, S., Bekker-Jensen, S., Mailand, N., Lukas, C., Bartek, J., & Lukas, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00492-06 · Cited by 182
Risques, R. A., Lai, L. A., Brentnall, T. A., Li, L., Feng, Z., Gallaher, J., Mandelson, M. T., Potter, J. D., Bronner, M. P., & Rabinovitch, P. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.008 · Cited by 179
Implications of Oxidative Stress and Cell Membrane Lipid Peroxidation in Human Cancer (Spain)
Cejas, P., Casado, E., Belda-Iniesta, C., De Castro, J., Espinosa, E., Redondo, A., Sereno, M., García-Cabezas, M. Á., Vara, J. A. F., Domínguez-Cáceres, A., et al. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036189.61607.52 · Cited by 177
Kuboki, Y., Nishina, T., Shinozaki, E., Yamazaki, K., Shitara, K., Okamoto, W., Kajiwara, T., Matsumoto, T., Tsushima, T., Mochizuki, N., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30425-4 · Cited by 176
Colorectal Cancer Disparity in African Americans
Augustus, G. J., & Ellis, N. A. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.07.023 · Cited by 176
Possible better long-term survival in left versus right-sided colon cancer - a systematic review.
Hansen, I. O., & Jess, P. (2012) · PubMed · Cited by 174
Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
Bensard, C. L., Wisidagama, D. R., Olson, K. A., Berg, J. A., Krah, N. M., Schell, J. C., Nowinski, S. M., Fogarty, S., Bott, A. J., Wei, P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.002 · Cited by 172
Shaked, H., Hofseth, L. J., Chumanevich, A. P., Chumanevich, A. A., Wang, J., Wang, Y., Taniguchi, K., Gumá, M., Shenouda, S., Clevers, H. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211509109 · Cited by 171
Hao, H.-X., Jiang, X., & Cong, F. (2016) · Cancers · doi:10.3390/cancers8060054 · Cited by 171
Hua, F., Shang, S., Yang, Y.-W., Zhang, H.-Z., Xu, T.-L., Yu, J.-J., Zhou, D.-D., Cui, B., Li, K., Lv, X.-X., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.10.031 · Cited by 171
Tao, Y., Kang, B., Petkovich, D. A., Bhandari, Y. R., In, J., Stein-O'Brien, G., Kong, X., Xie, W., Zachos, N., Maegawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.005 · Cited by 170
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 170
Wang, Y.-Q., Wang, H.-L., Xu, J., Tan, J., Fu, L.-N., Wang, J.-L., Zou, T.-H., Sun, D.-F., Gao, Q.-Y., Chen, Y.-X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02951-4 · Cited by 167
RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer
Chatterji, P., & Rustgi, A. K. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.008 · Cited by 166
Kojima, M., Morisaki, T., Sasaki, N., Nakano, K., Mibu, R., Tanaka, M., & Katano, M. (2004) · PubMed · Cited by 165
Vilar, E., Bartnik, C. M., Stenzel, S. L., Raskin, L., Ahn, J., Moreno, V. R., Mukherjee, B., Iniesta, M. D., Morgan, M. A., Rennert, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1120 · Cited by 164
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
Gros, A., Tran, E., Parkhurst, M. R., Ilyas, S., Pasetto, A., Groh, E. M., Robbins, P. F., Yossef, R., García-Garijo, A., Fajardo, C. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127967 · Cited by 164
Sherwood, A., Emerson, R., Scherer, D., Habermann, N., Buck, K., Staffa, J., Desmarais, C., Halama, N., Jaeger, D., Schirmacher, P., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1446-2 · Cited by 163
Caught in the cross fire: p53 in inflammation
Cooks, T., Harris, C. C., & Oren, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu134 · Cited by 162
Atkins, D., Breuckmann, A., Schmahl, G. E., Binner, P., Ferrone, S., Krummenauer, F., Störkel, S., & Seliger, B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11681 · Cited by 161
Evolutionary history of human colitis-associated colorectal cancer
Baker, A.-M., Cross, W., Curtius, K., Al Bakir, I., Choi, C.-H. R., Davis, H. L., Temko, D., Biswas, S., Martinez, P., Williams, M. J., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316191 · Cited by 161
D'Souza, N., Georgiou Delisle, T., Chen, M., Benton, S., & Abulafi, M. (2021) · Gut · doi:10.1136/gutjnl-2020-321956 · Cited by 161
Zhang, J., Tsoi, H., Li, X., Wang, H., Gao, J., Wang, K., Go, M. Y., Ng, S. C., Chan, F. K., Sung, J. J., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308614 · Cited by 160
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Yuan, H., Li, N., Fu, D., Ren, J., Hui, J., Peng, J., Liu, Y., Qiu, T., Jiang, M., Pan, Q., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94292 · Cited by 160
Metabolic control of regulatory T cell (Treg) survival and function by Lkb1
He, N., Fan, W., Henriquez, B., Yu, R. T., Atkins, A. R., Liddle, C., Zheng, Y., Downes, M., & Evans, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715363114 · Cited by 160
Mokarram, P., Albokashy, M., Zarghooni, M., Moosavi, M. A., Sepehri, Z., Chen, Q. M., Hudecki, A., Sargazi, A., Alizadeh, J., Moghadam, A. R., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1290751 · Cited by 159
Lung Cancer Subtypes Generate Unique Immune Responses
Busch, S., Hanke, M. L., Kargl, J., Metz, H. E., MacPherson, D. P., & Houghton, A. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600576 · Cited by 157
Wang, S., Qu, Y., Xia, P., Chen, Y., Zhu, X., Zhang, J., Wang, G., Tian, Y., Ying, J., & Fan, Z. (2020) · Cell Research · doi:10.1038/s41422-020-0312-y · Cited by 156
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.
Liao, H.-W., Hsu, J.-M., Xia, W., Wang, H.-L., Wang, Y.-N., Chang, W.-C., Arold, S. T., Chou, C.-K., Tsou, P.-H., Yamaguchi, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82826 · Cited by 155 · cited 1×
“Enhanced EGFR activation can occur via post-translational modifications involving methylation of R198 and R200 by protein arginine methyltransferase 1 (PRMT1), which enhances its binding to EGF and consequent signaling activation, even in the presence of the EGFR inhibitor (Liao et al. 2015).”
BackgroundTam, B. Y. Y., Chiu, K., Chung, H., Bossard, C., Nguyen, J. D., Creger, E., Eastman, B. W., Mak, C. C., Ibanez, M., Ghias, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.009 · Cited by 154
Cervantes, A. M. R., Élez, E., Roda, D., Ecsedy, J., Macarulla, T. M., Venkatakrishnan, K., Roselló, S., Andreu, J., Jung, J., Sanchis, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0571 · Cited by 153
Gordon-Weeks, A. N., Lim, S. Y., Yuzhalin, A. E., Jones, K. I., Markelc, B., Kim, K. J., Buzzelli, J. N., Fokas, E., Cao, Y., Smart, S., et al. (2017) · Hepatology · doi:10.1002/hep.29088 · Cited by 153
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
Kinoshita, M., Kayama, H., Kusu, T., Yamaguchi, T., Kunisawa, J., Kiyono, H., Sakaguchi, S., & Takeda, K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200420 · Cited by 152
Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer
Teng, S., Li, Y. E., Yang, M., Qi, R., Huang, Y., Wang, Q., Zhang, Y., Chen, S., Li, S., Lin, K., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0259-z · Cited by 151
Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
Matallanas, D., Romano, D., Al‐Mulla, F., O’Neill, E. E., Al-Ali, W., Crespo, P., Doyle, B. J., Nixon, C., Sansom, O. J., Drosten, M., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.016 · Cited by 149
Tumor necrosis is a new promising prognostic factor in colorectal cancer
Pollheimer, M. J., Kornprat, P., Lindtner, R. A., Harbaum, L., Schlemmer, A., Rehak, P., & Langner, C. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.04.018 · Cited by 146
Lannagan, T. R. M., Lee, Y. K., Wang, T., Roper, J., Bettington, M. L., Fennell, L., Vrbanac, L., Jonavicius, L., Somashekar, R., Gieniec, K. A., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315920 · Cited by 145
Colorectal Cancer and Metabolism
Brown, R. E., Short, S. P., & Williams, C. S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0420-y · Cited by 145
Li, J., Yu, B., Deng, P., Cheng, Y., Yu, Y., Kevork, K., Ramadoss, S., Ding, X., Li, X., & Wang, C.-Y. (2017) · Nature Communications · doi:10.1038/ncomms15146 · Cited by 144
Self-citationRedundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis
Housseau, F., Wu, S., Wick, E. C., Fan, H., Wu, X., Llosa, N. J., Smith, K. N., Tam, A., Ganguly, S., Wanyiri, J. W., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0749 · Cited by 143 · cited 1×
“Interestingly, if treated with the antibiotic cefoxitin, ETBF can be eliminated inmurinemodels followed by reduced tumorigenesis and IL-17A expression, indicating that ETBF plays a role in Th17 response (DeStefano Shields et al. 2016; Housseau et al. 2016).”
BackgroundNeutrophils in cancer development and progression: Roles, mechanisms, and implications (Review)
Zhang, X., Zhang, W., Yuan, X., Fu, M., Qian, H., & Xu, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3616 · Cited by 143
Tacconi, C., Correale, C., Gandelli, A., Spinelli, A., Dejana, E., D’Alessio, S., & Danese, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.005 · Cited by 141
Wu, C., Lyu, J., Yang, E. J., Liu, Y., Zhang, B., & Shim, J. S. (2018) · Nature Communications · doi:10.1038/s41467-018-05694-4 · Cited by 141
Tatsumoto, N., Hiyama, E., Murakami, Y., Imamura, Y., Shay, J. W., Matsuura, Y., & Yokoyama, T. (2000) · PubMed · Cited by 132
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer
Zhang, J., Roberts, T. M., & Shivdasani, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.010 · Cited by 130
Fisel, P., Schaeffeler, E., & Schwab, M. G. (2018) · Clinical and Translational Science · doi:10.1111/cts.12551 · Cited by 130
Itatani, Y., Kawada, K., Fujishita, T., Kakizaki, F., Hirai, H., Matsumoto, T., Iwamoto, M., Inamoto, S., Hatano, E., Hasegawa, S., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.033 · Cited by 125
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
Zheng, J., Yang, M. H., Shao, J., Miao, Y.-J., Han, J., & Du, J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-141 · Cited by 125
Liu, R., Lu, Z., Gu, J., Liu, J., Huang, E., Liu, X., Wang, L., Yang, J., Deng, Y., Qian, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.09.045 · Cited by 121
Mouse models for colorectal cancer
Heyer, J., Yang, K., Lipkin, M., Edelmann, W., & Kucherlapati, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203036 · Cited by 120
Han, T., Schatoff, E. M., Murphy, C. J., Zafra, M. P., Wilkinson, J. E., Elemento, O., & Dow, L. E. (2017) · Nature Communications · doi:10.1038/ncomms15945 · Cited by 120
Immune Activation in Mismatch Repair–Deficient Carcinogenesis: More Than Just Mutational Rate
Willis, J. A., Reyes-Uribe, L., Chang, K., Lipkin, S. M., & Vilar, E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0856 · Cited by 117
Bruun, J., Kryeziu, K., Eide, P. W., Moosavi, S. H., Eilertsen, I. A., Langerud, J., Røsok, B. I., Totland, M. Z., Brunsell, T. H., Pellinen, T. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3637 · Cited by 117
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Arena, S., Corti, G., Durinikova, E., Montone, M., Reilly, N. M., Russo, M., Lorenzato, A., Arcella, P., Lazzari, L., Rospo, G., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2409 · Cited by 115 · cited 1×
“…to understand the genetic bases of response to therapies (Calon et al. 2015; Vlachogiannis et al. 2018; Ganesh et al. 2019; Ooft et al. 2019; Arena et al. 2020; Yao et al. 2020), profile genomic alterations (Bolhaqueiro et al. 2019) and intratumoral heterogeneity (Roerink et al. 2018; Bruun…”
BackgroundRisio, M., Reato, G., di Celle, P. F., Fizzotti, M., Rossini, F. P., & Foà, R. (1996) · PubMed · Cited by 114
Leedham, S. J., Rodenas-Cuadrado, P., Howarth, K. M., Lewis, A., Mallappa, S., Segditsas, S., Belnoue-Davis, H. L., Jeffery, R. E., Rodriguez‐Justo, M., Keshav, S., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301601 · Cited by 114
Dietary and Microbial Metabolites in the Regulation of Host Immunity
Shibata, N., Kunisawa, J., & Kiyono, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02171 · Cited by 112
Peng, K., Kou, L., Li, Y., Bai, C., Li, M., Mo, P., Li, W., & Yu, C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.036 · Cited by 112
Housseau, F., & Sears, C. L. (2010) · Cell Cycle · doi:10.4161/cc.9.1.10352 · Cited by 110
S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand–Mediated Apoptosis in Cancer Cells
Leon-Bollotte, L., Selvakumar, S., Cauvard, O., Plenchette, S., Paul, C., Godard, C., Martínez-Ruiz, A., Legembre, P., Jeannin, J., & Bettaïeb, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.053 · Cited by 110
O'Regan, A. W., Hayden, J. M., & Berman, J. S. (2000) · PubMed · Cited by 108
Schmidt, S., Gay, D. M., Uthe, F. W., Denk, S., Paauwe, M., Matthes, N., Diefenbacher, M. E., Bryson, S., Warrander, F., Erhard, F., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0408-0 · Cited by 107
Bile acids and colon cancer: Is FXR the solution of the conundrum?
Gadaleta, R. M., García‐Irigoyen, O., & Moschetta, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.002 · Cited by 103
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer
López‐García, C., Sansregret, L., Domingo, E., McGranahan, N., Hobor, S., Birkbak, N. J., Horswell, S. D., Gronroos, E. C., Favero, F., Rowan, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.001 · Cited by 102
Targeting cancer-specific mutations by T cell receptor gene therapy
Blankenstein, T. J. F., Leisegang, M., Uckert, W., & Schreiber, H. W. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.005 · Cited by 101
NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor
Novellasdemunt, L., Kucharska, A., Jamieson, C., Prange‐Barczynska, M., Baulies, A., Antas, P., van der Vaart, J., Gehart, H., Maurice, M. M., & Li, V. S. W. (2019) · The EMBO Journal · doi:10.15252/embj.2019102771 · Cited by 101
Tseng-Rogenski, S. S., Hamaya, Y., Choi, D. H., & Carethers, J. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.11.027 · Cited by 100
Intestinal non-canonical NFκB signaling shapes the local and systemic immune response
Ramakrishnan, S. K., Zhang, H., Ma, X., Jung, I., Schwartz, A. J., Triner, D. A., Devenport, S. N., Das, N. K., Xue, X., Zeng, M. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08581-8 · Cited by 100
Self-citationKather, J. N., & Halama, N. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0441-6 · Cited by 100
Mouse models of colorectal cancer as preclinical models
McIntyre, R. E., Buczacki, S. J. A., Arends, M. J., & Adams, D. J. (2015) · BioEssays · doi:10.1002/bies.201500032 · Cited by 99
Krupitskaya, Y., & Wakelee, H. A. (2009) · PubMed · Cited by 98
Dendritic Cell Infiltration in Colon Cancer
Schwaab, T., Weiss, J. E., Schned, A. R., & Barth, R. J. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00007 · Cited by 96
Martin, S. A., Hewish, M., Sims, D., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2836 · Cited by 96
Shields, C. E. D., Meerbeke, S. W. V., Housseau, F., Wang, H., Huso, D. L., Casero, R. A., O’Hagan, H. M., & Sears, C. L. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw069 · Cited by 96
Jobin, G., Rodriguez-Suarez, R. J., & Betito, K. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.009 · Cited by 96
Dendritic cell defects in the colorectal cancer
Legitimo, A., Consolini, R., Failli, A., Orsini, G., & Spisni, R. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29857 · Cited by 95
Sarshekeh, A. M., Advani, S., Overman, M. J., Manyam, G. C., Kee, B. K., Fogelman, D. R., Dasari, A. N., Raghav, K. P. S., Vilar, E., Manuel, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173345 · Cited by 94
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis
Hilkens, J., Timmer, N. C., Boer, M., Ikink, G. J., Schewe, M., Sacchetti, A., Koppens, M. A. J., Song, J., & Bakker, E. R. M. (2016) · Gut · doi:10.1136/gutjnl-2016-311606 · Cited by 93
TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling
Jung, Y., Jun, S., Kim, M. J., Lee, S. H., Suh, H. N., Lien, E. M., Jung, H., Lee, S., Zhang, J., Yang, J., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0219-8 · Cited by 93
Kleeman, S. O., Koelzer, V. H., Jones, H. J. S., Vázquez, E. G., Belnoue-Davis, H. L., East, J. E., Arnold, R. R., Koppens, M. A. J., Blake, A., Domingo, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319126 · Cited by 92
Simons, C. C. J. M., Hughes, L., Smits, K. M., Bakker, C. A. J. K.-D., A, A. P. D. B., Carvalho, B. G., Meijer, G. A., Schouten, L. J., van den Brandt, P. A., Weijenberg, M. P., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt076 · Cited by 91
Terrin, L., Rampazzo, E., Pucciarelli, S., Agostini, M., Bertorelle, R., Esposito, G., DelBianco, P., Nitti, D., & De Rossi, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0478 · Cited by 91
Map of differential transcript expression in the normal human large intestine
LaPointe, L. C., Dunne, R. A., Brown, G. S., Worthley, D. L., Molloy, P. L., Wattchow, D. A., & Young, G. P. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00185.2006 · Cited by 90
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
Greenhough, A., Bagley, C., Heesom, K. J., Gurevich, D., Gay, D. M., Bond, M., Collard, T. J., Paraskeva, C., Martin, P. B., Sansom, O. J., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708699 · Cited by 89
Ji, Y., Yang, C., Tang, Z., Yang, Y., Tian, Y., Yao, H., Zhu, X. D., Zhang, Z., Ji, J., & Zheng, X. (2017) · Nature Communications · doi:10.1038/ncomms15308 · Cited by 87
Hou, Z., Guo, K., Sun, X., Hu, F., Chen, Q., Luo, X., Wang, G., Hu, J., & Sun, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0922-x · Cited by 86
Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis
Badiola, I., Olaso, E., Crende, O., Friedman, S. L., & Vidal‐Vanaclocha, F. (2011) · Gut · doi:10.1136/gutjnl-2011-300810 · Cited by 85
O'Regan, A. W., Hayden, J. M., & Berman, J. S. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.495 · Cited by 85
Chemoprevention of hereditary colon cancers: time for new strategies
Ricciardiello, L., Ahnen, D. J., & Lynch, P. M. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.56 · Cited by 84
Mirza‐Aghazadeh‐Attari, M., Darband, S. G., Kaviani, M., Mihanfar, A., Aghazadeh-Attari, J., Yousefi, B., & Majidinia, M. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.07.005 · Cited by 82
Telomere Length in the Colon Declines with Age: a Relation to Colorectal Cancer?
O'Sullivan, J. N., Risques, R. A., Mandelson, M. T., Chen, L., Brentnall, T. A., Bronner, M. P., MacMillan, M. P., Feng, Z., Siebert, J. R., Potter, J. D., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0542 · Cited by 81
TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Zhang, X., Li, C., Zhang, L., Wu, C., Han, L., Jin, G., Rezaeian, A. H., Han, F., Liu, C., Xu, C. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.002 · Cited by 81
Kawasaki, K., Fujii, M., Sugimoto, S., Ishikawa, K., Matano, M., Ohta, Y., Toshimitsu, K., Takahashi, S., Hosoe, N., Sekine, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.009 · Cited by 80
ArhGAP30 promotes p53 acetylation and function in colorectal cancer
Wang, J., Qian, J., Hu, Y., Kong, X., Chen, H., Shi, Q., Jiang, L., Wu, C., Zou, W., Chen, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms5735 · Cited by 79
Chiorean, E. G., Hurwitz, H. I., Cohen, R. B., Schwartz, J. D., Dalal, R., Fox, F. E., Gao, L., & Sweeney, C. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv144 · Cited by 78
Bertorelle, R., Briarava, M., Rampazzo, E., Biasini, L., Agostini, M., Maretto, I., Lonardi, S., Friso, M. L., Mescoli, C., Zagonel, V, et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.602 · Cited by 77
Telomere dysfunction activates YAP1 to drive tissue inflammation
Chakravarti, D., Hu, B., Mao, X., Rashid, A., Li, J., Li, J., Liao, W.-T., Whitley, E. M., Dey, P., Hou, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18420-w · Cited by 77
Self-citationRegression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice
He, G.-W., Günther, C., Thonn, V., Yu, Y., Martini, E., Buchen, B., Neurath, M. F., Stürzl, M., & Becker, C. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160442 · Cited by 76
Goswami, R. S., Patel, K. P., Singh, R. R., Meric‐Bernstam, F., Kopetz, S., Subbiah, V., Álvarez, R. H., Davies, M. A., Jabbar, K. J., Roy‐Chowdhuri, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2391 · Cited by 75
Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
Brown, K. M., Xue, A., Mittal, A., Samra, J. S., Smith, R. C., & Hugh, T. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11184 · Cited by 75
Tang, R., Cheng, A., Wang, J., & Wang, T. V. (1998) · PubMed · Cited by 73
Hochster, H. S., Bendell, J. C., Cleary, J. M., Foster, P., Zhang, W., He, X., Hernandez, G., Iizuka, K., & Eckhardt, S. G. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.673 · Cited by 71
Kiss, E. A., & Diefenbach, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00124 · Cited by 71
Colorectal cancers choosing sides
Albuquerque, C. M., Bakker, E. R. M., van Veelen, W., & Smits, R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.005 · Cited by 69
Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer
Tsai, W., You, J., Hung, H., Hsieh, P., Hsieh, B. R., Lenz, H., Idos, G., Friedland, S., Pan, J. Y.-J., Shao, H., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000088 · Cited by 66
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations
Foley, T. M., Payne, S. N., Pasch, C. A., Yueh, A. E., Hey, D. R. V. D., Korkos, D. P., Clipson, L. J., Maher, M. E., Matkowskyj, K. A., Newton, M. A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0256 · Cited by 65
Hinze, L., Labrosse, R., Degar, J., Han, T., Schatoff, E. M., Schreek, S., Karim, S., McGuckin, C., Sacher, J. R., Wagner, F. F., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1472 · Cited by 65
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
Ganesh, S., Koser, M. L., Cyr, W. A., Chopda, G. R., Tao, J., Shui, X., Ying, B., Chen, D., Pandya, P., Chipumuro, E., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0309 · Cited by 64
Kramer, H. B., Lai, C., Patel, H., Periyasamy, M., Lin, M., Feller, S. M., Fuller-Pace, F. V., Meek, D. W., Ali, S., & Buluwela, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv948 · Cited by 61
Cremolini, C., Loupakis, F., Masi, G., Lonardi, S., Granetto, C., Mancini, M. L., Chiara, S., Moretto, R., Rossini, D., Vitello, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw052 · Cited by 61
Joosten, S. P. J., Zeilstra, J., van Andel, H., Mijnals, R. C. D., Zaunbrecher, J., Duivenvoorden, A. A. M., van de Wetering, M., Clevers, H. C., Spaargaren, M., & Pals, S. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.008 · Cited by 60
Meisenberg, C., Ashour, M. E., El-Shafie, L., Liao, C., Hodgson, A., Pilborough, A., Khurram, S. A., Downs, J. A., Ward, S. E., & El-Khamisy, S. F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1026 · Cited by 59
The metabolic axis of macrophage and immune cell polarization
Hobson-Gutierrez, S., & Carmona‐Fontaine, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034462 · Cited by 59
Bauer, K. H., Nelius, N., Reuschenbach, M., Koch, M., Weitz, J., Steinert, G., Kopitz, J., Beckhove, P., Tariverdian, M., Doeberitz, M. V. K., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1303-8 · Cited by 58
Lim, S. Y., Gordon-Weeks, A. N., Allen, P. D., Kersemans, V., Beech, J. S., Smart, S., & Muschel, R. J. (2015) · Hepatology · doi:10.1002/hep.27838 · Cited by 57
Xu, X., Xu, J. M., Wu, J., Hu, Y., Han, Y., Gu, Y., Zhao, K., Zhang, Q., Liu, X., Liu, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.011 · Cited by 56
Diet and colon cancer: integration of the descriptive, analytic, and metabolic epidemiology.
Aj, M., & Potter, J. D. (1985) · PubMed · Cited by 55
Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin
Jung, Y., Wang, W., Jun, S., Zhang, J., Srivastava, M., Kim, M. J., Lien, E. M., Shang, J., Chen, J., McCrea, P. D., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0215-z · Cited by 55
Sakthianandeswaren, A., Parsons, M. J., Mouradov, D., MacKinnon, R. N., Catimel, B., Liu, S., Palmieri, M., Love, C. G., Jorissen, R. N., Li, S., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0909 · Cited by 54
Loyon, R., Jary, M., Salomé, B., Gomez‐Cadena, A., Galaine, J., Kroemer, M., Romero, P. J., Trabanelli, S., Adotévi, O., Borg, C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02121 · Cited by 54
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers
Shalapour, S., & Karin, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082019-081656 · Cited by 54
Self-citationKhoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52 · cited 1×
“…p53 mutant mice develop epithelial cancers, including CRC, whereas telomere-dysfunctional Ink4a/Arf-/- mice do not, underscoring the role of p53-dependentDNAdamage signaling in dictating whether telomere dysfunction can serve as a mutational mechanism driving carcinomas (Khoo et al. 2007).”
BackgroundSelf-citationColorectal premalignancy is associated with consensus molecular subtypes 1 and 2
Chang, K., Willis, J. A., Reumers, J., Taggart, M. W., San Lucas, F. A., Thirumurthi, S., Kanth, P., Delker, D. A., Hagedorn, C. H., Lynch, P. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy337 · Cited by 51
Seneviratne, D. S., Ma, J., Tan, X., Kwon, Y.-K., Muhammad, E., Melhem, M. F., DeFrances, M. C., & Zarnegar, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.09.019 · Cited by 51
Marchiò, S., Soster, M., Cardaci, S., Muratore, A., Bartolini, A., Barone, V., Ribero, D., Monti, M., Bovino, P., Sun, J. D., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101164 · Cited by 51
Koelzer, V. H., Dawson, H., Andersson, E. K., Karamitopoulou, E., Masucci, G. V., Lugli, A., & Zlobec, I. (2015) · Translational research · doi:10.1016/j.trsl.2015.02.008 · Cited by 50
Wang, S., Peng, Z., Wang, S., Yang, L., Chen, Y., Kong, X., Song, S., Pei, P., Tian, C., Yan, H., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0008-8 · Cited by 48
Cited by
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression
Hsu, W.-H., LaBella, K. A., Lin, Y., Xu, P., Lee, R., Hsieh, C.-E., Yang, L., Zhou, A., Blecher, J. M., Wu, C.-J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1467 · Cited by 125
Self-citationPostwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
The Role of ATP-Binding Cassette Subfamily A in Colorectal Cancer Progression and Resistance
Alketbi, L., Al-Ali, A., Talaat, I. M., Hamid, Q., & Bajbouj, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021344 · Cited by 20
An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer
Shahzad, M., Hameed, H., Amjad, A., Khan, M. A., Qureshi, I. S., Hameed, A., Saeed, A., & Munir, R. (2025) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-024-03482-0 · Cited by 7
Metadata
- Authors
- Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2021-06
- Volume
- 35
- Issue
- 11-12
- Pages
- 787-820
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W3165199846
- Cited by
- 573
- References
- 418
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.